Moreover, we found the FACT inhibitor, CBL0137, to be a promising viral sensitizer that improved VSVΔM51 replication in these and other human cancer lines known to be resistant to infection by VSVΔM51/VSVM51R oncolytic strains. The gene discussed is SSRP1; the disease is infection.